Anita Verghese
About Anita Verghese
Anita Verghese is a Senior Scientist at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical and biotechnology industries.
Current Role at Bristol Myers Squibb
Anita Verghese currently holds the position of Sr. Scientist at Bristol Myers Squibb. She joined the company in November 2019, bringing with her over two decades of experience in the pharmaceutical and biotechnology industries. Her role involves leveraging her extensive expertise in material science and engineering within the pharmaceutical sector.
Previous Experience at Celgene
Anita Verghese worked at Celgene for a total of 18 years. She began as an Associate Scientist from 2001 to 2008. She was then promoted to Scientist I, a role she held from 2008 to 2016. She eventually progressed to Scientist II, serving from 2016 until her departure in 2019. Her tenure at Celgene demonstrates a steady progression in responsibilities and contributions within the company.
Early Career Roles
Before her long-term tenure at Celgene, Anita Verghese worked as an Analytical Chemist at Ortho Clinical Diagnostics from 1999 to 2001 and at Sabinsa Corporation from 1995 to 1998. These roles helped her to build a strong foundation in analytical chemistry, which has been critical in her subsequent positions.
Educational Background
Anita Verghese has a diverse educational background. She holds a Master of Science in Environmental Science from the New Jersey Institute of Technology. Additionally, she earned a Bachelor of Science in Chemistry from All Saints' College, Thiruvananthapuram, and a Master of Science in Chemistry from Govt. College for Women, Thiruvananthapuram. This extensive education has equipped her with a broad and deep understanding of scientific principles.
Specialization in Material Science and Engineering
Anita Verghese specializes in material science and engineering within the pharmaceutical sector. Her long-standing career and varied roles have given her in-depth knowledge and expertise, especially as it pertains to the pharmaceutical and biotechnology industries.